Radiopharm Theranostics Ltd Adr stock is traded at $0.92, with a volume of 21,590. It is up +3.49% in the last 24 hours and down -22.03% over the past month. Radiopharm Theranostics Ltd is an Australian-based clinical-stage radiotherapeutics company targeting cancer. The company has a pipeline of approximately four licensed platform technologies, with diagnostic and therapeutic applications at both the pre-clinical and clinical stages of development. The company is engaged in research, development, and commercialization of health technologies.
Previous Close:
$0.889
Open:
$0.92
24h Volume:
21,590
Relative Volume:
0.32
Market Cap:
$14.45M
Revenue:
$2.34M
Net Income/Loss:
-$30.37M
P/E Ratio:
-
EPS:
-$2.94
Net Cash Flow:
-$23.42M
1W Performance:
-14.81%
1M Performance:
-22.03%
6M Performance:
-78.35%
1Y Performance:
-79.69%
1-Day Range:
$0.9$0.975
1-Week Range:
$0.82$1.09
52-Week Range:
$0.82$16.25
Radiopharm Theranostics Ltd Adr Stock (RADX) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS